Mexazolam and Alprazolam in the Treatment of Generalised Anxiety Disorder: A Double-Blind, Randomised Clinical Trial

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.21, Iss.4, 2001-04, pp. : 257-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Generalised Anxiety Disorder with Venlafaxine XR: A Randomised, Double-Blind Trial in Comparison with Buspirone and Placebo

By Rolland P.D.

Clinical Drug Investigation, Vol. 19, Iss. 2, 2000-02 ,pp. : 163-165

Adis International

Access to resources Recommend Favorite

A double-blind controlled study of PCR 7060 vs. buspirone in the treatment of generalised anxiety disorder

By Rouillon F. Lejoyeux M. Martineau C.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 367-367

Elsevier

Access to resources Recommend Favorite

Psychomotor and Anxiolytic Effects of Mexazolam in Patients with Generalised Anxiety Disorder

By Ferreira L.

Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. : 235-243

Adis International

Access to resources Recommend Favorite

Nimesulide versus Ibuprofen for Postoperative Tonsillectomy Pain: A Double-Blind, Randomised, Active Comparator-Controlled Clinical Trial

By Aho M.

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 651-660

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Three Regimens for Helicobacter pylori Eradication : A Multicentre, Double-Blind, Randomised Clinical Trial

By Bujanda L.

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite